PLACIDI, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 39.523
AS - Asia 6.295
EU - Europa 4.064
SA - Sud America 755
AF - Africa 111
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 12
Totale 50.777
Nazione #
US - Stati Uniti d'America 39.391
SG - Singapore 3.821
CN - Cina 915
IT - Italia 732
BR - Brasile 632
RU - Federazione Russa 577
DE - Germania 517
UA - Ucraina 498
IE - Irlanda 443
HK - Hong Kong 436
VN - Vietnam 425
GB - Regno Unito 278
FR - Francia 274
FI - Finlandia 200
KR - Corea 200
JP - Giappone 151
SE - Svezia 150
PL - Polonia 109
NL - Olanda 85
CA - Canada 78
IN - India 70
AR - Argentina 52
ID - Indonesia 49
MX - Messico 38
ES - Italia 37
ZA - Sudafrica 36
AT - Austria 34
BD - Bangladesh 30
IQ - Iraq 28
CZ - Repubblica Ceca 27
TR - Turchia 25
EG - Egitto 23
BE - Belgio 22
PH - Filippine 17
EC - Ecuador 15
AE - Emirati Arabi Uniti 13
AU - Australia 13
IL - Israele 13
CL - Cile 12
MA - Marocco 12
PK - Pakistan 12
GR - Grecia 11
PE - Perù 11
TN - Tunisia 11
DK - Danimarca 10
EU - Europa 10
KG - Kirghizistan 10
LT - Lituania 10
PY - Paraguay 10
UZ - Uzbekistan 10
VE - Venezuela 10
CO - Colombia 9
SA - Arabia Saudita 9
CH - Svizzera 8
MY - Malesia 8
NP - Nepal 8
ET - Etiopia 7
KE - Kenya 7
KZ - Kazakistan 7
PT - Portogallo 7
RO - Romania 7
BG - Bulgaria 6
DZ - Algeria 6
TH - Thailandia 6
TW - Taiwan 5
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
HU - Ungheria 4
JO - Giordania 4
AL - Albania 3
AM - Armenia 3
BO - Bolivia 3
GE - Georgia 3
JM - Giamaica 3
LB - Libano 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
SN - Senegal 3
SV - El Salvador 3
IR - Iran 2
LK - Sri Lanka 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BS - Bahamas 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
Totale 50.766
Città #
Woodbridge 10.620
Wilmington 9.971
Houston 8.771
Fairfield 1.361
Singapore 1.187
Ashburn 887
Ann Arbor 802
Chandler 656
San Jose 581
Seattle 572
Cambridge 473
Hong Kong 426
Beijing 406
Jacksonville 406
Dublin 405
Medford 307
New York 225
Council Bluffs 210
Rome 203
Santa Clara 199
Dearborn 174
The Dalles 162
Los Angeles 161
Lawrence 145
Ho Chi Minh City 135
Tokyo 119
Moscow 108
Lauterbourg 102
Helsinki 94
Hanoi 91
San Diego 89
Buffalo 83
Kraków 82
Menlo Park 82
Colorado Springs 77
São Paulo 76
Dallas 60
Milan 60
Boardman 57
Zhengzhou 57
Munich 48
London 47
Norwalk 44
Orem 43
Mülheim 41
North Bergen 33
Shanghai 31
Redwood City 30
Toronto 30
Nuremberg 29
Phoenix 29
Jakarta 28
Chicago 26
Stockholm 26
Palo Alto 25
Atlanta 24
Haiphong 24
Verona 24
Amsterdam 23
Columbus 23
Frankfurt am Main 23
Rio de Janeiro 23
Brno 22
Brooklyn 22
Brussels 22
Johannesburg 22
Guangzhou 21
Naples 21
Belo Horizonte 20
Da Nang 20
Manchester 20
Warsaw 20
Montreal 19
Mountain View 18
Vienna 18
Chennai 17
Denver 17
San Francisco 17
Washington 17
Boston 16
Daejeon 16
Istanbul 16
Seoul 16
Salt Lake City 15
University Park 15
Redondo Beach 14
Biên Hòa 13
Cairo 13
Falls Church 13
Kilburn 13
Hefei 12
Mexico City 12
Pune 12
Hangzhou 11
Miami 11
Mumbai 11
San Mateo 11
Brasília 10
Lappeenranta 10
Monte Porzio Catone 10
Totale 41.959
Nome #
Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt-Jakob disease 621
Dynamic susceptibility contrast (DSC) MRI and interictal epileptiform activity in cryptogenic partial epilepsy 585
Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2 580
Increased cortical excitability after selective REM sleep deprivation in healthy humans: a transcranial magnetic stimulation study 573
Spastic paraplegia, epilepsy, and mental retardation in several members of a family: a novel genetic disorder 556
Paucisymptomatic Marchiafava-Bignami disease with relevant diffusion-weighted MRI lesions 546
Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study 521
Coma, alterazioni della coscienza e sonno 514
Development of collateral veins as a favorable prognostic factor for complete recovery in cerebral venous thrombosis due to Tribulus terrestris 508
L-dopa-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment. 507
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 503
Pregabalin as add-on therapy induces REM sleep enhancement in partial epilepsy: A polysomnographic study 501
Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy. 497
Unexpected total recovery in a patient with post-anoxic complete alpha coma predicted by recording of cortical SEPs 497
Baroreflex Buffering of Sympathetic Activation during Sleep: Evidence from Autonomic Assessment of Sleep Macroarchitecture and Microarchitecture 495
Cognitive and psychiatric effects of topiramate monotherapy in migraine treatment: an open study. 482
Predicting seizures in untreated temporal lobe epilepsy using point-process nonlinear models of heartbeat dynamics 482
Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment 478
Effective treatment of narcolepsy-cataplexy with duloxetine: a report of three cases. 477
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 476
Continuous positive airway pressure treatment increases serum vitamin D levels in male patients with obstructive sleep apnea 472
Bilateral thalamic stroke due to nasal ephedrine and naphazoline use 470
Effects of epilepsy treatment on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics 466
Bilateral frontal polymicrogyria and epilepsy in a patient with Turner mosaicism: a case report 465
Multicenter case-control study on restless legs syndrome in multiple sclerosis: The REMS Study 464
Increasing cortical excitability: A possible explanation for the proconvulsant role of sleep deprivation 461
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 456
Cerebrovascular reactivity and subcortical infarctions 455
Unilateral spatial neglect and alien limb phenomenon may be early features of Creutzfeldt-Jakob disease 454
Topiramate: effect on EEG interictal abnormalities and background activity in patients affected by focal epilepsy. 450
Temporal lobe epileptic activity mimicking dementia: a case report 448
Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires 448
Nocturnal sleep and daytime somnolence in untreated patients with temporal lobe epilepsy: changes after treatment with controlled-release carbamazepine 445
Optic Nerve dysfunction in obstructive sleep apnea: An electrophysiological study 445
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease 444
Ketotic hyperglycemia and epilepsia partialis continua 443
Changes of the EEG paroxysmal pattern during felbamate therapy in Lennox-Gastaut syndrome: a case report. 443
Changes in nocturnal sleep and day time somnolence after CBZ administration [MODIFICAZIONI DEL SONNO NOTTURNO E DELLA SONNOLENZA DIURNA DOPO SOMMINISTRAZIONE DI CARBAMAZEPINA] 439
Pure ictal sensory seizures may represent a clinical manifestation of PLEDs 439
Restless legs syndrome and poliomyelitis: New evidences of an old observation? 438
Estrogen deficiency hampers the beneficial effect of continuous positive airway pressure therapy on serum vitamin D concentrations in postmenopausal women affected by obstructive sleep apnea 438
Fronto-central monomorphic theta activity as EEG pattern of ictal psychosis 434
Gabapentin as add-on therapy in focal epilepsy: a computerized EEG study 433
Pedunculopontine nucleus stimulation influences REM sleep in Parkinson's disease 432
Panic attacks as ictal manifestation of a meningioma of the left anterior clinoid [Attacchi di panico come manifestazioni critiche di un meningioma della clinoide anteriore sinistra] 431
Oxcarbazepine in Nocturnal Frontal-Lobe Epilepsy: A Further Interesting Report 431
Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study 431
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 429
Effects of zonisamide as add-on therapy on sleep-wake cycle in focal epilepsy: a polysomnographic study 428
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia 428
Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. 426
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 425
CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD 423
Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time 422
Panic disorder or epilepsy? A case report 421
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population 420
null 419
Sleep disorders in spinal and bulbar muscular atrophy (Kennedy's disease): a controlled polysomnographic and self-reported questionnaires study 415
Sleep in healthy elderly subjects: A 24-hour ambulatory polysomnographic study 411
Sleep-wake cycle and effects of cabergoline monotherapy in de novo Parkinson's disease patients - An ambulatory polysomnographic study 411
Gabapentin-induced modulation of interictal epileptiform activity related to different vigilance levels 411
A 23 years follow-up study identifies GLUT1 deficiency syndrome initially diagnosed as complicated hereditary spastic paraplegia 409
Spasticity as an ictal pattern due to excitotoxic upper motor neuron damage 408
Impairment of daytime cerebrovascular reactivity in patients with obstructive sleep apnoea syndrome 407
Rotigotine effect on sleep in a de novo Parkinson's Disease patient affected by periodic limb movement disorder 407
Topiramate-induced restless legs syndrome: A report of two cases [3] 400
Is autonomic nervous system involved in restless legs syndrome during wakefulness? 399
Sleep abnormalities in mentally retarded autistic subjects: Down's syndrome with mental retardation and normal subjects 394
May CSF beta-amyloid and tau proteins levels be influenced by long treatment duration and stable medication in narcolepsy? 390
Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study. 390
CSF beta-amyloid levels are altered in narcolepsy: a link with the inflammatory hypothesis? 389
Is autonomic nervous system involved in restless legs syndrome during wakefulness? 389
Multiple sleep latency test may be not sensitive in obstructive sleep apnea with comorbid narcolepsy revealed by low cerebrospinal fluid orexin levels 388
Electroencephalography and dementia: a literature review and future perspectives 387
Bilateral hemispheric activation in the early recovery of motor function after stroke 386
Restless legs syndrome and post polio syndrome: a case-control study 385
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 383
Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis 382
Case report: subependymal diffuse heterotopia. Clinical, EEG, and neuroimaging findings 379
Multiple idiosyncratic adverse effects of antiepileptic drugs in a patient with partial trisomy of chromosome 9 and epilepsy [Reazioni idiosincrasiche multiple a farmaci antiepilettici in una paziente con trisomia parziale del cromosoma 9 ed epilessia] 378
Cognitive profile and brain morphological changes in obstructive sleep apnea 377
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 375
Folic acid supplements during pregnancy in specific clinical settings: What dowe know about epilepsy? 373
Effect of antiepileptic drugs on sleep 369
MicroRNA expression is dysregulated in narcolepsy: A new evidence? 366
Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function 365
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study 365
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data 364
Ictal aphasia as manifestation of partial status epilepticus in a long-lasting misdiagnosed symptomatic epilepsy: An emblematic case 361
Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study 354
Obstructive sleep apnoea and bone health 353
Non-motor functions in parkinsonian patients implanted in the pedunculopontine nucleus: focus on sleep and cognitive domains. 349
Sleep-wake cycle in the Kennedy's disease: a controlled polysomnographic study and self-reported questionnaires 344
Pedunculopontine nucleus stimulation influences REM sleep in Parkinson's disease 343
Circadian variation of fatigue in paralytic poliomyelitis and postpolio syndrome: just fatigue or masked restless legs syndrome? 325
Evaluation of patients with focal epilepsy in the intercritical phase with perfusion mr imaging and eeg 320
Continuous positive airway pressure treatment may improve optic nerve function in obstructive sleep apnea: An electrophysiological study 314
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 311
Clinical case report: multiple idiosyncratic adverse effects of antiepileptic drugs in trisomy 9p 307
Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study 284
Totale 42.732
Categoria #
all - tutte 119.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.495


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021520 0 0 0 0 0 0 0 0 0 206 233 81
2021/20221.530 77 97 71 33 48 120 113 45 86 131 71 638
2022/20231.877 226 131 55 230 175 427 161 111 163 38 104 56
2023/2024763 104 23 35 40 66 230 31 57 13 24 15 125
2024/20255.189 132 734 396 219 79 449 157 173 342 243 1.307 958
2025/20265.999 473 273 763 616 546 267 931 787 747 596 0 0
Totale 51.257